Merck files pill for milder COVID, as AZ showcases its antibody dataAs expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral Share XMerck files pill for milder COVID, as AZ showcases its antibody datahttps://pharmaphorum.com/news/merck-files-pill-for-milder-covid-as-az-showcases-its-antibody-data/
UK trial begins testing second-wave COVID-19 drug from US biotech RidgebackThe AGILE programme, which is researching a second wave of COVID-19 therapies in the UK, has begun testing its first potential Share XUK trial begins testing second-wave COVID-19 drug from US biotech Ridgebackhttps://pharmaphorum.com/news/uk-trial-begins-testing-second-wave-covid-19-drug-from-us-biotech-ridgeback/
